Bill Status of HB 813   95th General Assembly

Short Description:  IDPH-CANCER DRUG REPOSITORY

House Sponsors
Rep. Karen May-Greg Harris-Harry Osterman-Patricia R. Bellock, Sara Feigenholtz, Elizabeth Hernandez, Carolyn H. Krause, Elizabeth Coulson, Elaine Nekritz, Lisa M. Dugan, Richard T. Bradley, Jack D. Franks and Linda Chapa LaVia

Senate Sponsors
(Sen. Jacqueline Y. Collins-Kirk W. Dillard-Pamela J. Althoff)


Last Action  View All Actions

DateChamber Action
  1/13/2009HouseSession Sine Die

Statutes Amended In Order of Appearance
New Act
225 ILCS 85/4from Ch. 111, par. 4124
225 ILCS 120/15from Ch. 111, par. 8301-15
320 ILCS 50/10
410 ILCS 620/16from Ch. 56 1/2, par. 516
720 ILCS 570/102from Ch. 56 1/2, par. 1102
740 ILCS 20/3from Ch. 70, par. 903

Synopsis As Introduced
Creates the Cancer Drug Repository Program Act. Requires the Department of Public Health to establish a cancer drug repository program, under which any person may donate a cancer drug or supplies needed to administer a cancer drug for use by an individual who meets eligibility criteria specified by the Department. Sets forth requirements that cancer drugs or supplies must meet in order to be accepted and dispensed under the program. Provides that no drugs or supplies donated under the cancer drug repository program may be resold. Provides that nothing in the Act requires that a medical facility, pharmacy, pharmacist, or practitioner participate in the cancer drug repository program. Provides for civil and criminal immunity for drug and supply manufacturers and individuals in relation to the donation, acceptance, or dispensing of cancer drugs or supplies under the cancer drug repository program. Requires the Department to adopt certain rules to implement the cancer drug repository program. Amends the Pharmacy Practice Act of 1987, the Wholesale Drug Distribution Licensing Act, the Senior Pharmaceutical Assistance Act, the Illinois Food, Drug and Cosmetic Act, the Illinois Controlled Substances Act, and the Cannabis and Controlled Substances Tort Claims Act to provide that persons engaged in donating or accepting, or packaging, repackaging, or labeling, prescription drugs to the extent permitted or required under the Cancer Drug Repository Program Act are exempt from provisions of those other Acts that might prohibit or otherwise regulate such activity.

House Amendment No. 1
Deletes the provisions of the Cancer Drug Repository Program Act and reinserts substantially similar provisions, creating the Cancer Drug Repository Program Act, but with changes that include the following: (1) deletes references to medical facilities, so that donations of cancer drugs may be made only on the premises of a pharmacy; (2) deletes a reference to the dispensing of a cancer drug or supplies by a pharmacist; (3) provides for a drug or supply manufacturer's immunity from liability unless that manufacturer's conduct was wilful and wanton (instead of unless the manufacturer exercised bad faith), and makes similar changes concerning other persons' immunity from liability; and (4) eliminates a provision that the liability from which a manufacturer is immune includes liability for failure to transfer or communicate product or consumer information or the expiration date of the donated cancer drug or supply.

Actions 
DateChamber Action
  2/7/2007HouseFiled with the Clerk by Rep. Karen May
  2/7/2007HouseFirst Reading
  2/7/2007HouseReferred to Rules Committee
  2/15/2007HouseAssigned to Health Care Availability and Access Committee
  2/23/2007HouseAdded Co-Sponsor Rep. Sara Feigenholtz
  2/28/2007HouseAdded Co-Sponsor Rep. Elizabeth Hernandez
  3/6/2007HouseHouse Amendment No. 1 Filed with Clerk by Health Care Availability and Access Committee
  3/6/2007HouseHouse Amendment No. 1 Adopted in Health Care Availability and Access Committee; by Voice Vote
  3/6/2007HouseDo Pass as Amended / Short Debate Health Care Availability and Access Committee; 013-000-000
  3/7/2007HousePlaced on Calendar 2nd Reading - Short Debate
  3/13/2007HouseSecond Reading - Short Debate
  3/13/2007HousePlaced on Calendar Order of 3rd Reading - Short Debate
  3/14/2007HouseAdded Chief Co-Sponsor Rep. Greg Harris
  3/14/2007HouseAdded Chief Co-Sponsor Rep. Harry Osterman
  3/14/2007HouseAdded Co-Sponsor Rep. Carolyn H. Krause
  3/14/2007HouseAdded Co-Sponsor Rep. Elizabeth Coulson
  3/14/2007HouseAdded Co-Sponsor Rep. Elaine Nekritz
  3/14/2007HouseAdded Co-Sponsor Rep. Lisa M. Dugan
  3/21/2007HouseAdded Chief Co-Sponsor Rep. Patricia R. Bellock
  3/21/2007HouseThird Reading - Short Debate - Passed 115-000-000
  3/21/2007HouseAdded Co-Sponsor Rep. Richard T. Bradley
  3/21/2007HouseAdded Co-Sponsor Rep. Jack D. Franks
  3/21/2007HouseAdded Co-Sponsor Rep. Linda Chapa LaVia
  3/22/2007SenateArrive in Senate
  3/22/2007SenatePlaced on Calendar Order of First Reading March 27, 2007
  4/19/2007SenateChief Senate Sponsor Sen. Jacqueline Y. Collins
  4/20/2007SenateFirst Reading
  4/20/2007SenateReferred to Rules
  4/25/2007SenateAssigned to Public Health
  4/25/2007SenateAdded as Alternate Chief Co-Sponsor Sen. Kirk W. Dillard
  5/15/2007SenatePostponed - Public Health
  5/15/2007SenateRule 3-9(a) / Re-referred to Rules
  11/9/2007SenateAdded as Alternate Chief Co-Sponsor Sen. Pamela J. Althoff
  5/15/2008SenateRule 2-10 Committee Deadline Established As May 22, 2008; Substantive House Bills Out of Committee
  1/13/2009HouseSession Sine Die

Back To Top